Opella’s expansion adds near-term delivery capacity for global consumer-health operations from Hyderabad and sets a 12-month hiring window for up to 500 roles. The BSL-3 plant increases local high-containment manufacturing capacity for animal vaccines, which can shorten lead times for poultry/cattle/swine/aquaculture vaccine supply and reduce reliance on imports for Indian buyers. Both moves increase competition for specialized life-sciences talent and BSL-3-grade vendors in the Hyderabad/Genome Valley cluster, affecting hiring costs and contractor availability over the next year.